{"disease":{"id":"mdr-tb","name":"mdr tb"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06671808","title":"HIV and Multi-Drug Resistant Tuberculosis: a Study on Clinical Outcomes","phase":"","overall_status":"COMPLETED","enrollment_count":222128,"lead_sponsor_name":"Zahedan University of Medical Sciences","has_results":false},{"nct_id":"NCT05175794","title":"Triage Test for All Oral DR-TB Regimen (TRiAD Study)","phase":"","overall_status":"COMPLETED","enrollment_count":786,"lead_sponsor_name":"Centre for the AIDS Programme of Research in South Africa","has_results":false},{"nct_id":"NCT03069534","title":"Study of Adjunctive Recombinant Human Interleukin-2 Therapy in Patients With MDR-TB","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT02758236","title":"Tuberculosis Research of INA-RESPOND On Drug Resistance","phase":"","overall_status":"COMPLETED","enrollment_count":490,"lead_sponsor_name":"Ina-Respond","has_results":true},{"nct_id":"NCT05824871","title":"A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"Shanghai Jiatan Pharmatech Co., Ltd","has_results":false},{"nct_id":"NCT03086486","title":"Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":181,"lead_sponsor_name":"Global Alliance for TB Drug Development","has_results":true},{"nct_id":"NCT07393438","title":"Acetohydroxamic Acid Combined With a Short-Course Regimen for MDR-TB (AHA-PLUS)","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Shanghai Pulmonary Hospital, Shanghai, China","has_results":false},{"nct_id":"NCT05278988","title":"A Study of Ultrashort PRS Regimen V in the Treatment of MDR-TB","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Shanghai Pulmonary Hospital, Shanghai, China","has_results":false},{"nct_id":"NCT04124055","title":"Saliva and Dried Blood Spot Therapeutic Drug Monitoring for MDR-TB in Tanzania","phase":"NA","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"Jan-Willem C Alffenaar","has_results":false},{"nct_id":"NCT05493267","title":"A Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TB","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Shanghai Pulmonary Hospital, Shanghai, China","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}